Movano is trading 6.7% lower at $6.71, with no clear catalyst for the decline identified in available coverage.
- On October 30, 2026, available coverage showed no company-specific announcement or other direct catalyst.
- Healthcare was up 2.32%, and search results did not establish a broader market cause; the reason for the decline remains unclear.